Director Research and Innovation, MedTech Europe
Patrick has joined MedTech Europe as of the 1st of September, as Director, EU Research & Innovation Partnership Policies. He will develop, promote, represent and lead the industry in EU Research and Innovation Partnerships or Programmes, working on European projects and interacting with the European Commission in the set-up, follow-up and coordination of European funding(ed) projects and any other similar EU initiatives.
Patrick will particularly lead MedTech Europe activities and representation in critical framework programmes such as Horizon 2020, Horizon Europe (2021 to 2027), EIT Health and others.
He was recently VP Europe at CEATech Healthcare Institute, based in Grenoble (France). He managed a significant number of EU collaborative projects, research infrastructures, coordination actions and networks of excellence. His scientific and technical expertise are in nanomedicine, drug delivery, medical imaging and innovative medical technologies. He is the [Patrick Boisseau] past Chairman of the European Technology Platform on Nanomedicine and the representative of MedTech Europe at the Inter-Association Task Force preparing the Public-Private Partnership on Health under Horizon Europe.
Patrick was educated as an agronomist at the National Agronomic Institute Paris-Grignon, and as an engineer at ENGREF (École Nationale du Génie Rural des Eaux et des Forêts), together with a specialisation in DEA Nutrition Humaine at the University PARIS VI (France).
6 blogs from the author
Posted on 05.10.2022
The new Innovative Health Initiative (IHI) has prompted companies in the medical technology industry to think about taking part in more EU projects. For some, this is a new opportunity to build on existing experience. For others, it’s a new venture. With the right preparation, there are real benefits on offer thanks to this exciting […]
Posted on 01.07.2022
From robotic surgery and wearables to connected devices and AI-powered diagnostics, medical technologies are reinventing healthcare. Europe’s medtech sector is making unprecedented investments in research & innovation – and joining the Innovative Healthcare Initiative for the first time. I sense that something big is happening in healthcare research. A tectonic shift in Europe’s health innovation […]
Posted on 23.06.2021
The medical technology sector welcomes the European Commission’s 3rd edition of the EU Research and Innovation Days (R&I Days). This event could not have come at a more important time, as this year marks the official launch of Horizon Europe, the EU’s most ambitious research and innovation program to date. The response to the Covid-19 […]
Posted on 19.03.2020
What key health questions should EU Research & Innovation (R&I) funding aim to address? The Horizon Europe (2021-2027) Health Cluster has provided an answer – well, six answers – which will shape R&I for most of the coming decade. This will also drive my own work in leading the R&I Partnership Policy of MedTech Europe. […]
Posted on 13.11.2019
AI – Artificial Intelligence – sounds like another buzzword floating in the air of Brussels when we talk about future R&D priorities. There are many interpretations of what AI means, while some people are already grumbling that it’s just another fad. Personally, I believe that now is the time for practical examples of deployment of […]
Posted on 26.04.2019
As European research and innovation funds extend their focus towards diagnostics, digital and medical technologies, medtech companies must be ready to engage. A major future EU public-private partnership in research and innovation is currently in gestation. I believe it could help to address some of the biggest challenges in modern healthcare – and its […]